Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
TRVI - OPERATING INCOME
Operating Income TRVI - Trevi Therapeutics, Inc.
-33.9 M
LAST VALUE
-2.20%
2 YEAR CAGR
-13.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR